LifeStance Health Group (LFST) Earnings Analysis

LifeStance Health Group (LFST) next reports earnings on 2026-08-06, consensus EPS 0.02 USD. Last quarter (2026-05-07) it beat with EPS 0.04 USD vs 0.01 USD est (+300%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 182.89.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LFST next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.02 USD
Revenue estimate0.41B

LFST earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.04 USD0.01 USD+300%Beat
2026-02-250.03 USD-0.00094 USD+3291.5%Beat
2025-11-060.00277 USD-0.01 USD+127.7%Beat
2025-08-07-0.01 USD-0.03 USD+66.7%Beat
2025-02-27-0.02 USD-0.04 USD+50%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

LFST valuation and analyst view

Trailing P/E182.89
Trailing EPS0.0599 USD
Price / book2.89
Dividend yield0.00%
Market cap4.29B
Analyst consensusBuy (9 buy / 2 hold / 0 sell)
Avg price target11.8 USD

Related research pages

Frequently asked questions

When is LifeStance Health Group (LFST)'s next earnings date?

LifeStance Health Group is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.02 USD and revenue estimate of 0.41B.

Did LFST beat earnings last quarter?

In its 2026-05-07 report, LFST posted EPS of 0.04 USD versus a 0.01 USD estimate — a beat of 300%.

What is LFST's earnings track record?

Over the last 5 reported quarters with consensus data, LFST beat estimates 5 times (100%).

What is LFST's current P/E ratio and EPS?

LFST trades at a trailing P/E of 182.89 on trailing EPS of 0.05989970666005619 USD.

What do analysts rate LFST?

Analyst consensus is "Buy" across 11 ratings (0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 11.8 USD.